Description

5-Bromo-2-[[[[[5-Methyl-2-(1-Methylethyl)Phenoxy]Acetyl]Amino]Thioxomethyl]Amino]-Benzoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex molecular architecture designed for targeted synthesis. This compound matters for its role as a critical building block in the development of novel active pharmaceutical ingredients (APIs), particularly in research areas requiring specific brominated benzoic acid derivatives. Pharmaceutical R&D teams and fine chemical manufacturers need this precise intermediate to facilitate the synthesis of complex molecules with potential therapeutic applications.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of novel drug candidates and active pharmaceutical ingredients (APIs).
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new chemical entities.
• Agrochemical Synthesis: Potential application as an intermediate in the development of advanced crop protection agents and herbicides.
• Material Science Research: Employed in the synthesis of specialized organic compounds for advanced polymeric or electronic materials.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.

Basic Information

Product Name	5-Bromo-2-[[[[[5-Methyl-2-(1-Methylethyl)Phenoxy]Acetyl]Amino]Thioxomethyl]Amino]-Benzoic Acid
CAS No.	530155-28-3
Molecular Formula	C21H22BrN3O4S
Molecular Weight	492.39 g/mol
Synonyms	5-Bromo-2-[[[[[5-methyl-2-(propan-2-yl)phenoxy]acetyl]amino]carbothioyl]amino]benzoic acid; 2-[(5-Bromo-2-carboxyphenyl)carbamothioyl]-N-[2-(5-methyl-2-propan-2-ylphenoxy)acetyl]acetamide; Benzoic acid, 5-bromo-2-[[[[[5-methyl-2-(1-methylethyl)phenoxy]acetyl]amino]thioxomethyl]amino]-; 530155-28-3; Thioamide derivative of brominated benzoic acid
EINECS	Contact for details

Quality Control

Our 5-Bromo-2-[[[[[5-Methyl-2-(1-Methylethyl)Phenoxy]Acetyl]Amino]Thioxomethyl]Amino]-Benzoic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be moisture-sensitive; keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.